HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sirilak Wangngae Selected Research

diphenyliodonium

8/2021Flavylium-Based Hypoxia-Responsive Probe for Cancer Cell Imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sirilak Wangngae Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 05/2021
1Hypoxia (Hypoxemia)
08/2021

Drug/Important Bio-Agent (IBA)

3Coloring Agents (Dyes)IBA
01/2022 - 08/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2022
1AnionsIBA
01/2022
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Indomethacin (Indometacin)FDA LinkGeneric
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Photosensitizing Agents (Photosensitizers)IBA
01/2022
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2022
1diphenyliodoniumIBA
08/2021
1Oxidoreductases (Dehydrogenase)IBA
08/2021
1Chalcone (Benzalacetophenone)IBA
05/2021
1Fluorescent Dyes (Fluorescent Probes)IBA
05/2021
1Anti-Bacterial Agents (Antibiotics)IBA
05/2021

Therapy/Procedure

2Precision Medicine
01/2022 - 01/2022
2Therapeutics
01/2022 - 01/2022
1Photochemotherapy (Photodynamic Therapy)
01/2022